Cancer

Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancer

Daiichi Sankyo is confident Enhertu can top Roche's ADC, and also expand the use of HER2 drugs into new cancers like HER2-positive gastric cancer – …

Read more

Show More

Related Articles

Back to top button